BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8223761)

  • 61. Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation.
    Maron BJ; Roberts WC; Edwards JE; McAllister HA; Foley DD; Epstein SE
    Am J Cardiol; 1978 May; 41(5):803-10. PubMed ID: 565583
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children.
    Tester DJ; Ackerman MJ
    Annu Rev Med; 2009; 60():69-84. PubMed ID: 18928334
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Sudden death during Holter electrocardiographic monitoring in a patient with hypertrophic cardiomyopathy].
    Sato M; Takenaka K; Yamashita T; Koike S; Natori K; Nakahara K
    J Cardiol; 1998 May; 31(5):297-303. PubMed ID: 9617660
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fatal potential of supraventricular tachycardia in hypertrophic cardiomyopathy.
    Munclinger MJ; Thornton AS; Schutte DP; Sliwa K
    Int J Cardiol; 2004 Feb; 93(2-3):335-7. PubMed ID: 14975578
    [No Abstract]   [Full Text] [Related]  

  • 65. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy.
    O'Mahony C; Lambiase PD; Rahman SM; Cardona M; Calcagnino M; Quarta G; Tsovolas K; Al-Shaikh S; McKenna W; Elliott P
    Europace; 2012 May; 14(5):724-33. PubMed ID: 22094454
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Arrhythmias and sudden death in hypertrophic cardiomyopathy.
    McKenna WJ; Firoozi S; Sharma S
    Card Electrophysiol Rev; 2002 Feb; 6(1-2):26-31. PubMed ID: 11984011
    [No Abstract]   [Full Text] [Related]  

  • 69. Sudden cardiac death risk stratification.
    Deyell MW; Krahn AD; Goldberger JJ
    Circ Res; 2015 Jun; 116(12):1907-18. PubMed ID: 26044247
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death.
    Yetman AT; McCrindle BW; MacDonald C; Freedom RM; Gow R
    N Engl J Med; 1998 Oct; 339(17):1201-9. PubMed ID: 9780340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Stress, depression and cardiac arrhythmias].
    Brunckhorst CB; Holzmeister J; Scharf C; Binggeli C; Duru F
    Ther Umsch; 2003 Nov; 60(11):673-81. PubMed ID: 14669705
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Electrophysiological investigation of patients with hypertrophic cardiomyopathy. Evidence that slowed intraventricular conduction is associated with an increased risk of sudden death.
    Saumarez RC
    Br Heart J; 1994 Dec; 72(6 Suppl):S19-23. PubMed ID: 7873318
    [No Abstract]   [Full Text] [Related]  

  • 73. Sudden cardiac death.
    Sra J
    Indian Heart J; 1999; 51(2):137-59. PubMed ID: 10407542
    [No Abstract]   [Full Text] [Related]  

  • 74. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
    Segura-Villalobos F; Hernández-Guerra AI; Wanguemert-Pérez F; Rodríguez-Pérez JC; Mendoza-Lemes H; Barriales-Villa R
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):604-606. PubMed ID: 28073646
    [No Abstract]   [Full Text] [Related]  

  • 77. Sudden Cardiac Death and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy.
    Moore B; Semsarian C; Chan KH; Sy RW
    Heart Lung Circ; 2019 Jan; 28(1):146-154. PubMed ID: 30392982
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insights into the pathogenesis of sudden cardiac death from analysis of circadian fluctuations of potential triggering factors.
    Hohnloser SH; Klingenheben T
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):428-33. PubMed ID: 7513870
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The investigation of sudden cardiac death.
    Davies MJ
    Histopathology; 1999 Feb; 34(2):93-8. PubMed ID: 10064386
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk stratification after myocardial infarction.
    Camm AJ; Fei L
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):401-16. PubMed ID: 7513868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.